Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 17 of 17 for “"ST6GAL1"”.
-
St6Gal1 Is Upregulated In Pancreatic Cancer Cells By Pro-Inflammatory Cytokines
The sialyltransferase ST6GAL1 is overexpressed in several cancers, including pancreatic ductal adenocarcinoma (PDAC). ST6GAL1 adds an α2-6-linked sialic acid to N-glycosylated membrane proteins, modifying their structure and function. Despite extensive research on how ST6GAL1 affects cell …
-
Expression of ST6GAL1 Imparts Stem-Like Cell Behaviors, Thereby Promoting Neoplasia
… 2022. ST6 β-galactoside α2,6-sialyltransferase (ST6GAL1) is a glycosyltransferase which is known to be upregulated in cancer. It acts as a master regulator of a cell by being the predominant sialyltransferase catalyzing the addition of a bulky negatively charged sialic acid to the galactose sugar …
-
Understanding the Protumorigenic Functions of ST6GAL1 in Glioblastoma Stemness and Metabolism
… bgalactoside a-2,6-sialyltransferase 1 (ST6Gal1) is elevated in most tumors including in normal and neoplastic stem cells. ST6Gal1 imparts oncogenic phenotypes such as invasion, apoptosis evasion, therapy resistance, TIC maintenance among others via sialylation of critical receptors like, …
-
Sialylation Of Tnfr1 By St6Gal1 Modulates Receptor Dynamics And Determines Cell Fate
… For example, sialyltransferase ST6GAL1 is notable for its high expression in various cancers, including breast, colon, ovarian, and pancreatic. ST6GAL1 introduces α2-6-linkage sialylation to N-glycans on proteins, endowing cancer cells with stem cell-like properties. This …
-
Novel role for ST6Gal1 sialyltransferase as a tumor driver in pancreatic ductal adenocarcinoma
ST6Gal1 sialyltransferase adds negatively charged sialic acid in an α2,6 linkage to N-glycans on glycoproteins bound for the cell surface/secretion thus altering receptor structure, function and downstream signaling pathways. ST6Gal1 is upregulated in multiple cancers, including pancreatic, and …
-
ST6GAL1 from the Blood to the Gut: Influence on Myelopoiesis and Gastrointestinal Radiation Sensitivity
… glycan, built primarily by the sialyltransferase ST6GAL1, is α2,6-linked sialic acid occurring on N-linked glycan chains of cell surface and secreted proteins. α2,6-linked sialic acids have been shown to mediate numerous cellular events, from controlling hematopoiesis and inflammatory cell …
-
Sialylation of Epidermal Growth Factor Receptor by the Sialyltransferase ST6GAL1 Modulates Receptor Activity and Downstream Signaling
… acid which is added by the sialyltransferase, ST6GAL1. ST6GAL1 is upregulated in numerous malignancies and acts by adding an α2,6 sialic acid onto receptors bound for the plasma membrane. This sialic acid, in turn, modulates the activity of the receptor by regulating conformation, clustering, …
-
Role of alpha 2,6-linked sialylated galactose on intestinal epithelial glycans in regulating sex-specific mucus-microbe interactions and protection from colitis
… beta-galactoside alpha-2,6-sialyltransferase 1 (ST6Gal1), which has been well-studied in the context of the immune system. The role of α2,6-linked Sia in gut health and preventing disease is poorly defined, and data looking at sex-specificity and sialylation is limited, with most studies not …
-
Improvement of Erythropoietin N-glycan Branching and Sialylation by Overexpression of Glycosyltransferases
… level, a human α2,6-sialytransferase (ST6GAL1) was expressed in Chinese hamster ovary (CHO-K1) cells which produce recombinant human erythropoietin (EPO). In addition, both UDP-N-acetylglucosamine: α-1,3-D-mannoside β1,4-N-acetylglucosaminyltransferase (GNTIV/Mgat4 ) and …
-
Kinetics and Physiological Outcomes of Influenza A Viruses Infection on Multiple Cell Lines
… trypsin; sialyltransferase (ST3GAL1/6, ST6GAL1/2) and IL-8/KCNN4 mRNA were measured by qPCR; nonparametric tests with false discovery rate (FDR) correction and correlation analyses were applied. With trypsin, permissiveness followed a consistent hierarchy: MDCK cells overexpressing human …
-
Regulation Of St6Gal-I In Cancer: Sox2 Identified As Novel Driver Of St6Gal-I Expression
… unknown. Herein we highlight that SOX2 and ST6GAL1 are both located on one of the most commonly amplified chromosomal segments in cancer, amplicon 3q26. Copy number gains in both SOX2 and ST6GAL1 are observed in roughly 25% of an ovarian cancer cohort available through the The Cancer Genome …
-
DEVELOPING ANTIBODY DRUG CONJUGATE PLATFORMS VIA METABOLIC AND GENETIC GLYCOENGINEERING
… beta-galactoside alpha-2,6-sialyltransferase 1 (ST6GAL1) was introduced into a previously characterized UDP-GlcNAc 2- epimerase/ManNAc kinase (Gne) knockout CHO-K1 cell line. This new cell line was designated as CHO G6 and examined for its potential to incorporate high-flux, tri-butyrated …
-
Using Metabolic and Genetic Engineering to Develop Novel Cell Platforms for the Production of Recombinant Glycoproteins with Enhanced Pharmacokinetic Properties
… serum half-life. A CHO cell line expressing ST6GAL1, a sialyltransferase found in humans but naturally silent in CHO cells, and producing FIX was successfully created. FIX will provide an excellent test protein to demonstrate that the Yarema Lab’s metabolic analogs can be used to increase …
-
Glycoengineering of Chinese Hamster Ovary cells for improving biotherapeutics’ efficacies.
… α-2,3 sialylation on IgGF241A. Overexpressing ST6GAL1 in ST3GALs knockout CHO cells and expressing a mutant IgG with four amino acid replacements resulted in an highly sialylated IgG, with predominant α-2,6 sialylation. The last part of this study focused on generating hypergalactosylated IgGs …
-
INVESTIGATION OF GLYCOENZYME SUBSTRATE SPECIFICITY FOR GLYCOENGINEERING OF THERAPEUTIC ANTIBODIES
… and the human -2,6-sialyltransferase (ST6Gal1), to determine which is more efficient at sialylating intact antibody Fc glycans. We found that HcST-22 was more efficient than Pd2,6ST and ST6Gal-1 at sialylating intact Fc glycans. For my second project, I contributed to a collaborative …
-
Exploring novel mechanisms underlying synovial fibroblast-mediated pathogenesis in arthritis: role of ARNO and sialylation in stromal inflammation
… glycosylation by inhibiting the expression of ST6Gal1 and subsequently reducing α2-6 sialylation. In addition, SFs from arthritic mice exhibited reduced cell surface sialylation and sialylation was associated with functional SF subsets. Removal of cell surface sialic acid with sialidase from C. …
-
Populations to pathways: characterisation, clustering, genetics, and data-driven drug repurposing for post-acute COVID-19
… and mucosal barriers, such as SLC6A20 and ST6GAL1; alongside some subtype-specific signals for fatigue-related clusters, like RAB18 and BMP6. Mendelian randomisation and Bayesian modelling approaches were consistent with the fact that while PCC shares substantial genetic overlap with …